对阿尔茨海默氏症疾病发展遗传风险因素的全面审查
Aniket Kakkar1, Harpreet Singh1, Amit Anand2
1Faculty of Pharmacy, IFTM University, Moradabad, 244102, India.
Current gene therapy
|September 24, 2025
概括
阿尔茨海默病的遗传包括罕见的突变和常见的变异,如APOE ε4.4. 了解这些遗传因素是开发阿尔茨海默病个性化预防和治疗策略的关键.
科学领域:
- 神经遗传学 神经遗传学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,具有复杂的遗传结构.
- 遗传因素,包括罕见突变和常见变异,对AD病变产生有显著的贡献.
- 已确定的风险因素包括APP,PSEN1,PSEN2和APOE ε4等位基因对晚期发作的AD的突变.
研究的目的:
- 提供阿尔茨海默病遗传风险因素的综合分析.
- 审查已建立和新兴的基因位置及其相关的生物途径.
- 突出表观遗传学和基因环境相互作用在AD中的作用.
主要方法:
- 对阿尔茨海默病遗传学研究的文献综述.
- 综合了孟德尔遗传学,全基因组协会研究 (GWAS) 和表观遗传学研究的发现.
- 对AD病原和风险调节的遗传贡献的分析.
主要成果:
- 确定了与AD相关的关键基因 (APP,PSEN1,PSEN2,APOE,TREM2,CLU,ABCA7,SORL1),这些基因与AD相关.
- 突出了涉及的各种途径,包括粉样蛋白代谢,脂质调节和免疫反应.
- 强调了表观遗传修饰和基因环境相互作用在阿尔茨海默病风险和进展中的作用.
结论:
- 在识别导致阿尔茨海默病的遗传因素方面取得了重大进展.
- 将遗传发现转化为AD的临床应用仍然是一个挑战.
- 需要进行综合性,多种和人口多样性的研究,以提高AD风险预测和个性化干预措施.
关键词:
ABCA7A7ABCA7A7A7A7A ABCA7A7A ABCA7A7 ABCA7A7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7 ABCA7在这里,APOEOE是APOE.阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.在GWAS中,GWAS就是GWAS.这就是SORL1的原因.在TREM2中,我们可以使用TREM2.这是表观遗传学.遗传风险因素 遗传风险因素更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
15.6K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
12.2K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Human Genetics
1.5K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.5K
Alzheimer's Disease: Treatment
824
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
824
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Biological Causes of Schizophrenia
501
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
501
Dementia
523
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
523
